Single award · contract
Glaxosmithkline Adjuvant AS03
Award ID: W15QKN20C0048
FY2020 · complete year · data as of 2026-07-12
A single federal award, with both ends of the trail linked.
$335.6M
Total award value
Award W15QKN20C0048 is a contract from the Department of Defense to Glaxosmithkline, LLC, $335.6M obligated, FY2020 to FY2023, for Glaxosmithkline Adjuvant AS03. The work is performed in North Carolina. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source
Agency ›
Department of Defense
Source
awarded→$335.6M
Recipient ›
Glaxosmithkline, LLC
Source
performed in→
Award details
Award typeContract
PIIDW15QKN20C0048
Action date2020
Period29 mo
Awarding agencyDepartment of Defense →
RecipientGlaxosmithkline, LLC →
Place of performanceNorth Carolina →
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$335,592,191
More awards to Glaxosmithkline, LLC
awarded 2021$1.6B
awarded 2017$682.2M
awarded 2014$602M
awarded 2012$554.8M
awarded 2021$279.9M
More from Department of Defense
awarded 2016$51.3B
awarded 2017$35.7B
awarded 2017$35.1B
awarded 2001$34.2B
awarded 2011$32B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.